Journal of General Virology, Vol 78, 2529-2539, Copyright © 1997 by Society for General Microbiology

ARTICLES

Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys

F Titti, L Sernicola, A Geraci, G Panzini, S Di Fabio, R Belli, F Monardo, A Borsetti, MT Maggiorella, M Koanga-Mogtomo, F Corrias, R Zamarchi, A Amadori, L Chieco-Bianchi and P Verani
Laboratory of Virology, Istituto Superiore di Sanita, Rome, Italy.

The ability of a live attenuated simian immunodeficiency virus (SIV) to protect against challenge with cloned SIVmac251/BK28 was evaluated in four cynomolgus macaques. The intravenous infection of the C8 variant of the SIVmac251/32H virus, carrying an in-frame 12 bp deletion in the nef gene, did not affect the CD4+ and CD8+ cell counts, and a persistent infection associated with an extremely low virus burden in peripheral blood mononuclear cells (PBMCs) was established. After 40 weeks, these monkeys were challenged intravenously with a 50 MID50 dose of SIVmac251/BK28 virus grown on macaque cells. Four naive monkeys were infected as controls. Monkeys were monitored for 62 weeks following challenge. Attempts to rescue virus from either PBMCs or bone marrow from the C8-vaccinated monkeys were unsuccessful, but in two cases virus was re-isolated from lymph node cells. The presence of the SIV provirus with the C8 variant genotype maintaining its original nef deletion was shown by differential PCR in PBMCs, lymph nodes and bone marrow. Furthermore, in contrast to the control monkeys, the vaccinated monkeys showed normal levels for CD4+ and CD8+ cells, minimal lymphoid hyperplasia and no clinical signs of infection. Our results confirm that vaccination with live attenuated virus can confer protection. This appears to be dependent on the ability of the C8 variant to establish a persistent but attenuated infection which is necessary for inducing an immune response, as suggested by the persistence of a strong immune B cell memory and by the over-expression of interleukin (IL)-2, interferon-gamma and IL-15 mRNAs in PBMCs of C8-vaccinated monkeys but not in those of control monkeys.

This article has been cited by other articles:

				V. Buffa, D. R. M. Negri, P. Leone, R. Bona, M. Borghi, I. Bacigalupo, D. Carlei, C. Sgadari, B. Ensoli, and A. Cara A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)HXB2 Rev/Env or codon-optimized HIV-1JR-FL gp120 generates durable immune responses in mice J. Gen. Virol., June 1, 2006; 87(6): 1625 - 1634. [Abstract] [Full Text] [PDF]

				P. t. Haaft, E. J. Verschoor, B. Verstrepen, H. Niphuis, R. Dubbes, W. Koornstra, W. Bogers, B. Rosenwirth, and J. L. Heeney Readily acquired secondary infections of human and simian immunodeficiency viruses following single intravenous exposure in non-human primates J. Gen. Virol., December 1, 2004; 85(12): 3735 - 3745. [Abstract] [Full Text] [PDF]

				D. R. M. Negri, S. Baroncelli, S. Catone, A. Comini, Z. Michelini, M. T. Maggiorella, L. Sernicola, F. Crostarosa, R. Belli, M. G. Mancini, et al. Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge J. Gen. Virol., May 1, 2004; 85(5): 1191 - 1201. [Abstract] [Full Text] [PDF]

				E. Khatissian, V. Monceaux, M.-C. Cumont, M.-P. Kieny, A.-M. Aubertin, and B. Hurtrel Persistence of Pathogenic Challenge Virus in Macaques Protected by Simian Immunodeficiency Virus SIVmac{Delta}nef J. Virol., February 1, 2001; 75(3): 1507 - 1515. [Abstract] [Full Text]

				R. J. Gorelick, R. E. Benveniste, J. D. Lifson, J. L. Yovandich, W. R. Morton, L. Kuller, B. M. Flynn, B. A. Fisher, J. L. Rossio, M. Piatak Jr., et al. Protection of Macaca nemestrina from Disease following Pathogenic Simian Immunodeficiency Virus (SIV) Challenge: Utilization of SIV Nucleocapsid Mutant DNA Vaccines with and without an SIV Protein Boost J. Virol., December 15, 2000; 74(24): 11935 - 11949. [Abstract] [Full Text]

				P. Mooij, W. M. J. M. Bogers, H. Oostermeijer, W. Koornstra, P. J. F. Ten Haaft, B. E. Verstrepen, G. Van Der Auwera, and J. L. Heeney Evidence for Viral Virulence as a Predominant Factor Limiting Human Immunodeficiency Virus Vaccine Efficacy J. Virol., May 1, 2000; 74(9): 4017 - 4027. [Abstract] [Full Text]

				D. L. Sodora, K. E. Sheridan, P. A. Marx, and R. I. Connor Immunization with a Live, Attenuated Simian Immunodeficiency Virus Vaccine Leads to Restriction of Viral Diversity in Rhesus Macaques Not Protected from Pathogenic Challenge J. Virol., May 1, 1999; 73(5): 4443 - 4446. [Abstract] [Full Text]

				S. Carl, A. J. Iafrate, J. Skowronski, C. Stahl-Hennig, and F. Kirchhoff Effect of the Attenuating Deletion and of Sequence Alterations Evolving In Vivo on Simian Immunodeficiency Virus C8-Nef Function J. Virol., April 1, 1999; 73(4): 2790 - 2797. [Abstract] [Full Text]

				P Caufour, R Le Grand, A Cheret, O Neildez, F Theodoro, B Boson, B Vaslin, and D Dormont Secretion of beta-chemokines by bronchoalveolar lavage cells during primary infection of macaques inoculated with attenuated nef-deleted or pathogenic simian immunodeficiency virus strain mac251 J. Gen. Virol., March 1, 1999; 80(3): 767 - 776. [Abstract]

				U. Dittmer, D. M. Brooks, and K. J. Hasenkrug Characterization of a Live-Attenuated Retroviral Vaccine Demonstrates Protection via Immune Mechanisms J. Virol., August 1, 1998; 72(8): 6554 - 6558. [Abstract] [Full Text] [PDF]